Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Atrial fibrillation, Cardiac failure, Dyspnoea
Clinical narrative: double pneumonia; kidney failure; lung disease; heart failure; Sepsis; acute hypoxemic respiratory failure; persistent atrial fibrillation with rvr; acute kidney injury; hypernatremia; granulomatosis with polyangitis with multisystem involvement; intra-alveolar hemorrhage; volume overload; vancomycin-resistant enterococci (vre); infection due to esbl-producing klebsiella pneumonia; infection due to esbl-producing klebsiella pneumonia; Extreme hypoxemia (71); difficulty breathing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 12:45 (Lot number: ER8727) at the age of 70 years as dose 2, single and administered in arm left, administration date 08Mar2021 12:30 (Lot number: EN6205) as dose 1, single for covid-19 immunisation. Relevant medical history included: "penicillin" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. The following information was reported: PNEUMONIA (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "double pneumonia"; RENAL FAILURE (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "kidney failure"; LUNG DISORDER (hospitalization, disability, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "lung disease"; CARDIAC FAILURE (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "heart failure"; SEPSIS (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "Sepsis"; HYPOXIA (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "Extreme hypoxemia (71)"; DYSPNOEA (caused and prolonged hospitalization, disability, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "difficulty breathing"; ACUTE RESPIRATORY FAILURE (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "acute hypoxemic respiratory failure"; ATRIAL FIBRILLATION (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "persistent atrial fibrillation with rvr"; ACUTE KIDNEY INJURY (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "acute kidney injury"; HYPERNATRAEMIA (caused and prolonged hospitalization, disability, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "hypernatremia"; GRANULOMATOSIS WITH POLYANGIITIS (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "granulomatosis with polyangitis with multisystem involvement"; PULMONARY ALVEOLAR HAEMORRHAGE (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "intra-alveolar hemorrhage"; HYPERVOLAEMIA (caused and prolonged hospitalization, disability, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "volume overload"; ENTEROCOCCAL BACTERAEMIA (caused and prolonged hospitalization, disability, medically significant, life threatening) with onset 08Mar2021, outcome "recovered with sequelae", described as "vancomycin-resistant enterococci (vre)"; INFECTION (caused and prolonged hospitalization, disability, life threatening), PNEUMONIA KLEBSIELLA (caused and prolonged hospitalization, disability, medically significant, life threatening) all with onset 08Mar2021, outcome "recovered with sequelae" and all described as "infection due to esbl-producing klebsiella pneumonia". The patient was hospitalized and prolonged hospitalization for pneumonia, renal failure, cardiac failure, sepsis (start date: 06Apr2021, discharge date: 12Apr2021, hospitalization duration: 6 day(s)); for lung disorder (start date: 06Apr2021, discharge date: 12Apr2021, hospitalization duration: 6 day(s)); for hypoxia, dyspnoea (start date: 16Apr2021, discharge date: 20Apr2021, hospitalization duration: 4 day(s)); for acute respiratory failure, atrial fibrillation, acute kidney injury, hypernatraemia, granulomatosis with polyangiitis, pulmonary alveolar haemorrhage, hypervolaemia, enterococcal bacteraemia, infection, pneumonia klebsiella (start date: 20Apr2021, discharge date: 04Jun2021, hospitalization duration: 45 day(s)). The events "double pneumonia", "kidney failure", "lung disease", "heart failure", "sepsis", "extreme hypoxemia (71)", "difficulty breathing", "acute hypoxemic respiratory failure", "persistent atrial fibrillation with rvr", "acute kidney injury", "hypernatremia", "granulomatosis with polyangitis with multisystem involvement", "intra-alveolar hemorrhage", "volume overload", "vancomycin-resistant enterococci (vre)", "infection due to esbl-producing klebsiella pneumonia" and "infection due to esbl-producing klebsiella pneumonia" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (Apr2021) negative, notes: Nasal swab; (May2021) negative, notes: Nasal swab; (Jun2021) negative, notes: Nasal swab; (27Nov2021) negative, notes: Nasal swab. Therapeutic measures were taken as a result of pneumonia, renal failure, lung disorder, cardiac failure, sepsis, hypoxia, dyspnoea, acute respiratory failure, atrial fibrillation, acute kidney injury, hypernatraemia, granulomatosis with polyangiitis, pulmonary alveolar haemorrhage, hypervolaemia, enterococcal bacteraemia, infection, pneumonia klebsiella. Patient admitted on, 16Apr2021, Extreme hypoxemia (71), difficulty breathing. Intubated in ICU on 17Apr2021, given last rites. Needs higher quality of care. Airlifted to (withheld) ICU 20Apr2021- 04Jun2021, acute hypoxemic respiratory failure, persistent atrialfibrillation with rvr, acute kidney injury, hypernatremia granulomatosis with polyangitis with multisystem involvement, intra-alveolar hemorrhage, volume overload, vancomycin-resistant enterococci (vre),infection due to ESBL-producing Klebsiella pneumonia, SEPSIS, Prior to vaccination, was the patient diagnosed with COVID-19?:No, Since the vaccination, has the patient been tested for COVID-19?:Yes  No follow-up attempts are possible. No further information is expected.